Elite Pharmaceuticals (ELTP) News Today $0.19 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 21, 2024 | nz.finance.yahoo.comIntercontinental Exchange Inc (IC2.BE)July 11, 2024 | investorplace.comELTP Stock Earnings: Elite Pharmaceuticals Reported Results for Q4 2024June 13, 2024 | investorplace.com7 Strong Buy Penny Stocks to Buy Now: June 2024May 20, 2024 | finanznachrichten.deElite Pharmaceuticals, Inc.: Elite Pharmaceuticals Receives FDA Approval for Generic MethotrexateApril 26, 2024 | msn.comElite global firm McKinsey in US Justice Department hot chair over Opioid crisisApril 17, 2024 | finance.yahoo.comElite Pharmaceuticals, Inc. (ELTP)February 16, 2024 | finance.yahoo.comElite Pharmaceuticals, Inc. (PNK:ELTP) Q3 2024 Earnings Call TranscriptFebruary 14, 2024 | finance.yahoo.comElite Pharmaceuticals Inc Reports Significant Revenue and Operating Profit Growth in Q3 Fiscal 2024February 14, 2024 | finance.yahoo.comElite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call InformationFebruary 8, 2024 | finance.yahoo.comElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024February 6, 2024 | marketbeat.comElite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Crosses Above Fifty Day Moving Average of $0.16Elite Pharmaceuticals (OTCMKTS:ELTP) Shares Pass Above 50 Day Moving Average of $0.16January 15, 2024 | thestreet.comElite Pharmaceuticals, Inc.December 26, 2023 | finance.yahoo.comElite Pharmaceuticals Files ANDA with US FDA to Market Central Nervous System StimulantDecember 12, 2023 | msn.comElite Pharmaceuticals makes first product shipment of generic Adderall XR to PrascoDecember 12, 2023 | finance.yahoo.comElite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR(R) to Marketing Partner Prasco, LLCNovember 24, 2023 | morningstar.comElite Pharmaceuticals Inc ELTPNovember 20, 2023 | finance.yahoo.comElite Pharmaceuticals, Inc. (PNK:ELTP) Q2 2024 Earnings Call TranscriptNovember 14, 2023 | msn.comElite Pharmaceuticals reports Q3 resultsNovember 14, 2023 | finance.yahoo.comElite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 ended September 30, 2023 and Provides Conference Call InformationNovember 10, 2023 | finance.yahoo.comElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2024 Financial Results on November 15, 2023September 25, 2023 | finance.yahoo.comElite Pharmaceuticals Files ANDA with US FDA to Market Opiate Analgesic ProductSeptember 7, 2023 | msn.comElite Pharmaceuticals reappoints Carter Ward as CFOSeptember 7, 2023 | finance.yahoo.comElite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial OfficerAugust 28, 2023 | finanznachrichten.deElite Pharmaceuticals, Inc.: Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence StudyAugust 28, 2023 | benzinga.comThis Week's Top OTC Nano-Caps (ATVK, ELTP, EBET, ENZC)August 22, 2023 | benzinga.comDiscover the Potential: "Top Penny Stocks to Watch Now": SNNC, TIVC, ENZC, ELTP, CLNVAugust 14, 2023 | seekingalpha.comElite Pharmaceuticals reports Q1 resultsAugust 14, 2023 | finance.yahoo.comElite Pharmaceuticals, Inc. Reports Financial Results for First Quarter of Fiscal Year 2024 ended June 30, 2023 and Provides Conference Call InformationAugust 9, 2023 | finance.yahoo.comElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2024 Financial Results on August 15, 2023July 2, 2023 | finance.yahoo.comElite Pharmaceuticals, Inc. (PNK:ELTP) Q4 2023 Earnings Call TranscriptJune 29, 2023 | finance.yahoo.comElite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2023 and Provides Conference Call InformationJune 23, 2023 | finance.yahoo.comELTP - Elite Pharmaceuticals, Inc.June 22, 2023 | finance.yahoo.comElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2023 Financial Results on June 30, 2023May 3, 2023 | finance.yahoo.comElite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial OfficerApril 21, 2023 | marketwatch.comTrenbolone Enanthate Market 2023-2030April 20, 2023 | finanznachrichten.deElite Pharmaceuticals, Inc.: Elite Pharmaceuticals Files ANDA with US FDA to Market Antimetabolite ProductApril 20, 2023 | msn.comElite Pharmaceuticals seeks FDA approval for generic antimetabolite drugApril 20, 2023 | finance.yahoo.comElite Pharmaceuticals Files ANDA with US FDA to Market Antimetabolite ProductMarch 17, 2023 | seekingalpha.comELTP Elite Pharmaceuticals, Inc.February 14, 2023 | finance.yahoo.comElite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023 ended December 31, 2022 and Provides Conference Call InformationFebruary 8, 2023 | finance.yahoo.comElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2023 Financial Results on February 15, 2023December 23, 2022 | finanznachrichten.deElite Pharmaceuticals, Inc.: Elite Pharmaceuticals Files ANDA with US FDA to Market Dopamine AgonistDecember 22, 2022 | finance.yahoo.comElite Pharmaceuticals Files ANDA with US FDA to Market Dopamine AgonistNovember 15, 2022 | seekingalpha.comElite Pharmaceuticals, Inc. (ELTP) Q2 2023 Earnings Call TranscriptNovember 15, 2022 | finance.yahoo.comElite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2023 Ended September 30, 2022 and Provides Conference Call InformationNovember 8, 2022 | finance.yahoo.comElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2023 Financial Results on November 15, 2022November 2, 2022 | finance.yahoo.comElite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence StudySeptember 18, 2022 | wsj.comLisata Therapeutics Inc.August 16, 2022 | finance.yahoo.comElite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2023 ended June 30, 2022, and Provides Conference Call InformationAugust 11, 2022 | finance.yahoo.comElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2023 Financial Results on August 16, 2022 Get Elite Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ELTP and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here ELTP Media Mentions By Week ELTP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELTP News Sentiment▼-0.500.62▲Average Medical News Sentiment ELTP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELTP Articles This Week▼20▲ELTP Articles Average Week Get Elite Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ELTP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Nuvation Bio News Evolus News Wave Life Sciences News Phibro Animal Health News Stoke Therapeutics News Travere Therapeutics News Zymeworks News Scholar Rock News Arbutus Biopharma News Phathom Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ELTP) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elite Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elite Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
